泓博医药(301230)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301230 泓博医药

已收盘 09-03 15:00:00

{"stockData":{"symbol":"301230","market":"SZ","secType":"STK","nameCN":"泓博医药","latestPrice":38.15,"timestamp":1756883019000,"preClose":37.52,"halted":0,"volume":7496505,"delay":0,"changeRate":0.0168,"floatShares":76860300,"shares":140000000,"eps":0.1854,"marketStatus":"已收盘","change":0.63,"latestTime":"09-03 15:00:00","open":37.75,"high":39.15,"low":37.44,"amount":288000000,"amplitude":0.0456,"askPrice":38.16,"askSize":133,"bidPrice":38.15,"bidSize":55,"shortable":0,"etf":0,"ttmEps":0.1854,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756949400000},"marketStatusCode":5,"adr":0,"adjPreClose":37.52,"symbolType":"stock","openAndCloseTimeList":[[1756863000000,1756870200000],[1756875600000,1756882800000]],"highLimit":41.27,"lowLimit":33.77,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":139586605,"isCdr":false,"pbRate":4.94,"roa":"--","peRate":205.771305,"roe":"2.37%","epsLYR":0.12,"committee":0.124579,"marketValue":5325000000,"turnoverRate":0.0975,"status":0,"floatMarketCap":2932000000},"requestUrl":"/m/hq/s/301230","defaultTab":"news","newsList":[{"id":"2563706798","title":"泓博医药（301230）2025年中报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2563706798","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563706798?lang=zh_cn&edition=full","pubTime":"2025-08-29 06:44","pubTimestamp":1756421093,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期泓博医药发布2025年中报。截至本报告期末，公司营业总收入3.53亿元，同比上升32.73%，归母净利润2476.14万元，同比上升54.99%。按单季度数据看，第二季度营业总收入1.83亿元，同比上升35.75%，第二季度归母净利润1278.76万元，同比上升3.89%。本报告期泓博医药盈利能力上升，毛利率同比增幅17.46%，净利率同比增幅16.77%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082900007370.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230"],"gpt_icon":0},{"id":"2562742967","title":"泓博医药：上半年净利2476.14万元，同比增54.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562742967","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562742967?lang=zh_cn&edition=full","pubTime":"2025-08-27 21:45","pubTimestamp":1756302326,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0216","301230"],"gpt_icon":0},{"id":"2562742393","title":"泓博医药：2025年上半年净利润2476.14万元，同比增长54.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562742393","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562742393?lang=zh_cn&edition=full","pubTime":"2025-08-27 21:42","pubTimestamp":1756302168,"startTime":"0","endTime":"0","summary":"泓博医药公告，2025年上半年营业收入3.53亿元，同比增长32.73%。净利润2476.14万元，同比增长54.99%。公司拟以实施利润分配方案时股权登记日已发行总股本扣除回购股份数为基数，向全体股东每10股派发现金红利0.7元（含税），送红股0股（含税），不以公积金转增股本。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/27214252755907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301230"],"gpt_icon":0},{"id":"2562715491","title":"8月27日泓博医药跌5.79%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2562715491","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562715491?lang=zh_cn&edition=full","pubTime":"2025-08-27 16:32","pubTimestamp":1756283523,"startTime":"0","endTime":"0","summary":"证券之星消息，8月27日泓博医药跌5.79%，收盘报37.93元，换手率16.34%，成交量12.56万手，成交额4.98亿元。重仓泓博医药的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共6家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A目前规模为4.21亿元，最新净值1.2863，较上一交易日下跌0.84%，近一年上涨45.13%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082700033903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"gpt_icon":0},{"id":"2562965227","title":"股市必读：8月25日泓博医药现2笔大宗交易 机构净买入204.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562965227","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562965227?lang=zh_cn&edition=full","pubTime":"2025-08-26 03:56","pubTimestamp":1756151770,"startTime":"0","endTime":"0","summary":"截至2025年8月25日收盘，泓博医药报收于41.34元，上涨4.68%，换手率16.07%，成交量12.35万手，成交额5.01亿元。当日关注点交易信息汇总：8月25日，泓博医药主力资金净流入628.85万元，散户资金净流入2215.32万元，而游资资金净流出2844.17万元。大宗交易8月25日泓博医药现2笔大宗交易，机构净买入204.2万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082600007075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"gpt_icon":0},{"id":"2560916760","title":"泓博医药8月19日现1笔大宗交易 总成交金额785.8万元 溢价率为-1.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560916760","media":"新浪证券-红岸工作室","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560916760?lang=zh_cn&edition=full","pubTime":"2025-08-19 17:40","pubTimestamp":1755596400,"startTime":"0","endTime":"0","summary":"　　8月19日，泓博医药收跌0.50%，收盘价为39.77元，发生1笔大宗交易，合计成交量20万股，成交金额785.8万元。　　第1笔成交价格为39.29元，成交20.00万股，成交金额785.80万元，溢价率为-1.21%，买方营业部为东兴证券股份有限公司上海陆家嘴证券营业部，卖方营业部为国都证券股份有限公司北京东中街证券营业部。　　进一步统计，近3个月内该股累计发生4笔大宗交易，合计成交金额为3104.97万元。该股近5个交易日累计上涨7.63%，主力资金合计净流入4336.44万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-08-19/doc-infmpiza1162742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0216","301230"],"gpt_icon":0},{"id":"2557467053","title":"AI医疗概念盘中拉升，泓博医药涨14.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557467053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557467053?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:39","pubTimestamp":1754444343,"startTime":"0","endTime":"0","summary":"08月06日，AI医疗概念盘中拉升，截至09点38分，AI医疗概念整体指数上涨0.58%，报1023.540点。从个股上来看，该概念的成分股中，泓博医药涨14.80%，思创医惠、药石科技、成都先导涨幅居前。从资金上来看，截止发稿，AI医疗概念概念主力净流入为3830.78万，其中嘉和美康受到资金热捧，主力净流入1176.14万；拉长时间线来看，该板块近20日主力资金净流入-7.56亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806093903a6d576eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806093903a6d576eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688246","BK0231","159891","301230","BK0216"],"gpt_icon":0},{"id":"2557345059","title":"创新药概念盘中拉升，泓博医药涨15.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557345059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557345059?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:38","pubTimestamp":1754444294,"startTime":"0","endTime":"0","summary":"08月06日，创新药概念盘中拉升，截至09点38分，创新药概念整体指数上涨0.55%，报1254.180点。从个股上来看，该概念的成分股中，泓博医药涨15.35%，君实生物-U、热景生物2只个股涨幅超过10%，辰欣药业、海特生物等3只股涨幅超过5%。从资金上来看，截止发稿，创新药概念主力净流入为1.09亿，其中药明康德受到资金热捧，主力净流入6500.44万；拉长时间线来看，该板块近20日主力资金净流入-186.17亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080609381497366f24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080609381497366f24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1997245094.SGD","BK0216","LU2328871848.SGD","LU2495084118.USD","LU1979443071.USD","LU2488822045.USD","301230","02359","LU0456842615.SGD","LU1934453819.USD","LU1969619763.USD","LU1997244956.HKD","603367","603259","LU1997245177.USD","159992"],"gpt_icon":0},{"id":"2557639072","title":"泓博医药股价小幅回落 中报预增43.96%至69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557639072","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557639072?lang=zh_cn&edition=full","pubTime":"2025-08-05 22:39","pubTimestamp":1754404788,"startTime":"0","endTime":"0","summary":"截至2025年8月5日收盘，泓博医药股价报37.84元，较前一交易日下跌1.51%。当日成交量为6.06万手，成交额达2.30亿元。泓博医药属于生物制品行业，公司主营业务涵盖医药研发、生产和销售。根据公开信息，泓博医药预计2025年1-6月归属于上市公司股东的净利润为2300万元至2700万元，同比增长43.96%至69%。这一业绩预增信息使得公司新增\"2025中报预增\"概念。近五日主力资金累计净流出1.42亿元，占流通市值的4.89%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/05223952230558.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0216","301230"],"gpt_icon":0},{"id":"2555351950","title":"7月29日泓博医药涨5.66%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2555351950","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555351950?lang=zh_cn&edition=full","pubTime":"2025-07-29 16:23","pubTimestamp":1753777399,"startTime":"0","endTime":"0","summary":"证券之星消息，7月29日泓博医药涨5.66%创60日新高，收盘报40.87元，换手率22.01%，成交量16.91万手，成交额6.79亿元。重仓泓博医药的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级1家，增持评级1家。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共6家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A目前规模为4.21亿元，最新净值1.1694，较上一交易日上涨0.51%，近一年上涨28.63%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072900026548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"gpt_icon":0},{"id":"2552705460","title":"泓博医药：AI药物设计平台覆盖新药早期研发多个关键环节","url":"https://stock-news.laohu8.com/highlight/detail?id=2552705460","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552705460?lang=zh_cn&edition=full","pubTime":"2025-07-18 20:52","pubTimestamp":1752843123,"startTime":"0","endTime":"0","summary":"投资者提问：2025年，泓博医药还与默沙东、辉瑞、罗氏等开展了合作，分别涉及抗癌药物中间体生产与AI工艺优化、抗感染药物发现与AI虚拟筛选、CMC环节的AI稳定性预测等领域？公司自主研发的AI药物设计平台覆盖新药早期研发的多个关键环节，包括项目立项调研、化合物设计、专利性分析、活性评估和成药性研究等。平台采用模块化架构，结合AI算法与专业知识，在提升研发效率和精度方面取得了显著成效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071800036377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"gpt_icon":0},{"id":"2551214595","title":"7月16日泓博医药跌7.09%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2551214595","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551214595?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:16","pubTimestamp":1752653768,"startTime":"0","endTime":"0","summary":"证券之星消息，7月16日泓博医药跌7.09%，收盘报36.68元，换手率16.61%，成交量12.77万手，成交额4.74亿元。重仓泓博医药的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级1家，增持评级1家。根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A目前规模为5.49亿元，最新净值1.0768，较上一交易日上涨1.38%，近一年上涨15.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600025294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"gpt_icon":0},{"id":"2551690599","title":"7月14日泓博医药涨10.08%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2551690599","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551690599?lang=zh_cn&edition=full","pubTime":"2025-07-14 16:22","pubTimestamp":1752481334,"startTime":"0","endTime":"0","summary":"证券之星消息，7月14日泓博医药涨10.08%创60日新高，收盘报39.44元，换手率22.4%，成交量17.21万手，成交额6.55亿元。重仓泓博医药的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级1家，增持评级1家。根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A目前规模为5.49亿元，最新净值1.0552，较上一交易日上涨1.19%，近一年上涨12.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071400021739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"gpt_icon":0},{"id":"2551905178","title":"泓博医药涨10.08%，太平洋二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2551905178","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551905178?lang=zh_cn&edition=full","pubTime":"2025-07-14 16:22","pubTimestamp":1752481323,"startTime":"0","endTime":"0","summary":"今日泓博医药涨10.08%，收盘报39.44元。2025年4月29日，太平洋研究员周豫,张崴发布了对泓博医药的研报《Q1收入快速增长，利润增速超预期》，该研报对泓博医药给出“买入”评级。研报中预计2025年-2027年公司营收为7.39/9.89/12.99亿元，同比增长35.79%/33.79%/31.34%；归母净利为0.47/0.65/1.00亿元，对应PE为80/57/37倍，持续给予“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为31.22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071400021734.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","301230"],"gpt_icon":0},{"id":"2549511444","title":"7月8日泓博医药涨5.15%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2549511444","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549511444?lang=zh_cn&edition=full","pubTime":"2025-07-08 16:30","pubTimestamp":1751963419,"startTime":"0","endTime":"0","summary":"证券之星消息，7月8日泓博医药涨5.15%，收盘报35.15元，换手率13.62%，成交量10.47万手，成交额3.66亿元。重仓泓博医药的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级1家，增持评级1家。根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A目前规模为5.49亿元，最新净值1.0348，较上一交易日下跌0.67%，近一年上涨7.88%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070800026240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"gpt_icon":0},{"id":"2549511459","title":"泓博医药涨5.15%，太平洋二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2549511459","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549511459?lang=zh_cn&edition=full","pubTime":"2025-07-08 16:30","pubTimestamp":1751963402,"startTime":"0","endTime":"0","summary":"今日泓博医药涨5.15%，收盘报35.15元。2025年4月29日，太平洋研究员周豫,张崴发布了对泓博医药的研报《Q1收入快速增长，利润增速超预期》，该研报对泓博医药给出“买入”评级。研报中预计2025年-2027年公司营收为7.39/9.89/12.99亿元，同比增长35.79%/33.79%/31.34%；归母净利为0.47/0.65/1.00亿元，对应PE为80/57/37倍，持续给予“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为31.22%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070800026235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","601099"],"gpt_icon":0},{"id":"2549567706","title":"AI医疗概念盘中拉升，泓博医药涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549567706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549567706?lang=zh_cn&edition=full","pubTime":"2025-07-08 09:39","pubTimestamp":1751938751,"startTime":"0","endTime":"0","summary":"07月08日，AI医疗概念盘中拉升，截至09点39分，AI医疗概念整体指数上涨0.62%，报900.670点。从个股上来看，该概念的成分股中，泓博医药涨5.20%，成都先导、药石科技、迪安诊断涨幅居前。从资金上来看，截止发稿，AI医疗概念概念主力净流入为987.41万，其中成都先导受到资金热捧，主力净流入779.73万；拉长时间线来看，该板块近20日主力资金净流入-14.05亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708093911979db395&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708093911979db395&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159891","BK0216","301230","688222"],"gpt_icon":0},{"id":"2543648954","title":"合成生物概念盘中拉升，泓博医药涨11.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543648954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543648954?lang=zh_cn&edition=full","pubTime":"2025-06-16 09:40","pubTimestamp":1750038000,"startTime":"0","endTime":"0","summary":"06月16日，合成生物概念盘中拉升，截至09点39分，合成生物概念整体指数上涨0.72%，报1166.550点。从个股上来看，该概念的成分股中，泓博医药涨11.52%，博瑞医药涨幅超过5%。从资金上来看，截止发稿，合成生物概念主力净流入为-4609.79万，其中博瑞医药受到资金热捧，主力净流入4370.74万；拉长时间线来看，该板块近20日主力资金净流入-120.52亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506160940009781262c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506160940009781262c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","301230","688166","BK0216"],"gpt_icon":0},{"id":"2541813216","title":"每周股票复盘：泓博医药（301230）大宗交易折价23.36%，股东减持137.0万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2541813216","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541813216?lang=zh_cn&edition=full","pubTime":"2025-06-07 13:54","pubTimestamp":1749275648,"startTime":"0","endTime":"0","summary":"截至2025年6月6日收盘，泓博医药报收于32.95元，较上周的32.44元上涨1.57%。6月3日盘中最低价报31.8元。泓博医药当前最新总市值45.99亿元，在医疗服务板块市值排名32/50，在两市A股市值排名3160/5148。股本股东变化6月6日，泓博医药发布公告称，持股5%以上的股东沈阳富邦投资有限责任公司在6月4日合计减持了137.0万股，占公司目前总股本的0.9815%。在变动期间，该股股价上涨4.39%，截至6月4日收盘报34.97元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060700011675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"gpt_icon":0},{"id":"2541852339","title":"泓博医药(301230.SZ)股东沈阳富邦完成减持 累计减持1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2541852339","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541852339?lang=zh_cn&edition=full","pubTime":"2025-06-06 19:46","pubTimestamp":1749210383,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泓博医药(301230.SZ)公告，公司股东沈阳富邦减持股份计划已实施完毕，沈阳富邦通过集中竞价和大宗交易方式累计减持公司股份137万股，减持比例为1.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1302454.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","301230"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1756941697800,"stockEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.007},{"period":"3month","weight":0.1668},{"period":"6month","weight":0.0717},{"period":"1year","weight":0.9293},{"period":"ytd","weight":0.5093}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":0.0643},{"period":"3month","weight":0.1269},{"period":"6month","weight":0.1308},{"period":"1year","weight":0.3605},{"period":"ytd","weight":0.1378}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海泓博智源医药股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"16289人(较上一季度增加6.36%)","perCapita":"4718股","listingDate":"2022-11-01","address":"上海市浦东新区庆达路315号23幢","registeredCapital":"13958万元","survey":"　　上海泓博智源医药股份有限公司的主营业务是药物发现、制药工艺的研究开发以及原料药中间体的商业化生产。公司的主要产品是药物发现、工艺研究与开发、商业化生产。公司新申请专利14项，其中发明专利7项，实用新型7项。截至报告期末，公司已获得43项国内外专利授权，其中国内授权专利42项，美国授权专利1项，取得软件著作权1项。","listedPrice":40},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泓博医药(301230)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泓博医药(301230)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泓博医药,301230,泓博医药股票,泓博医药股票老虎,泓博医药股票老虎国际,泓博医药行情,泓博医药股票行情,泓博医药股价,泓博医药股市,泓博医药股票价格,泓博医药股票交易,泓博医药股票购买,泓博医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泓博医药(301230)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泓博医药(301230)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}